The Impact of Age of Diagnosis in Children with Primary Ciliary Dyskinesia

Dvir Gatt1, Michelle Shaw2, Fiona Kritzinger1

  • 1Division of Respiratory Medicine, and.

PubMed

Insights

Early diagnosis of primary ciliary dyskinesia (PCD) is linked to better lung function in children. Delayed diagnosis (age ≥8) in PCD patients correlates with lower forced expiratory volume in 1 second, highlighting the importance of timely intervention.

Area of Science:

  • Pediatric Pulmonology
  • Rare Genetic Diseases
  • Clinical Outcomes Research

Background:

  • Primary ciliary dyskinesia (PCD) symptoms typically appear in infancy, but diagnosis is often delayed.
  • The impact of diagnostic age on long-term clinical outcomes in PCD remains under-investigated.
  • Early identification is crucial for managing chronic respiratory conditions in children.

Purpose of the Study:

  • To investigate the association between the age of diagnosis for PCD and subsequent long-term clinical outcomes.
  • To determine if earlier diagnosis of PCD in pediatric patients leads to improved health trajectories.
  • To quantify the effects of delayed PCD diagnosis on lung function and disease exacerbations.

Main Methods:

  • Retrospective cohort study of 110 patients diagnosed with PCD between 2000 and 2022.
  • Patients categorized into three groups based on age at diagnosis: early (<1 year), typical (1-7 years), and late (8-14 years).
  • Comparison of clinical outcomes including forced expiratory volume in 1 second (FEV1) and pulmonary exacerbation rates.

Main Results:

  • Early diagnosis was associated with higher rates of neonatal respiratory distress (80%) and laterality defects (64%).
  • Patients diagnosed early (<1 year) or typically (1-7 years) exhibited significantly better FEV1 at age 10 compared to late-diagnosed patients (93.5% and 93.1% vs. 80.2%).
  • Late diagnosis (≥8 years) correlated with significantly higher annual rates of pulmonary exacerbations (1.95 vs. 0.75 per year).

Conclusions:

  • Delayed diagnosis of PCD in childhood is associated with persistently lower lung function (FEV1).
  • While the rate of lung function decline did not differ post-diagnosis, earlier identification is crucial.
  • These findings underscore the detrimental impact of delayed diagnosis on the long-term health of pediatric PCD patients.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
196
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
146
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
76
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244